← Eichor
Study identifier: NCT05525702 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

Condition: Delirium  ·  Sponsor: Peking Union Medical College Hospital

PhaseNA
Planned participants102
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn the effect of Virtual Reality Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is: ·Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes? Researchers will investigate whether the implementation of VRFS can reduce the number of delirium days and improve clinical outcomes. Participants will: * Receive the VRFS intervention until the endotracheal tube (ETT) is removed. * Have physiological data collected, including EEG, oxygen saturation levels, ECG, and blood pressure. * Keep a diary of delirium, dosage of sedative and analgesic drugs, the duration of mechanical ventilation, and ICU stays.

This description comes directly from the study's public registry record.

Talk to the study team

Yingying Yang, MD  ·  +8618800173833  ·  yangyingying2703@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

PUMCBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05525702